QURE

uniQure NV (QURE)

uniQure NV

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:QURE

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2025/01/09	06:25	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:QURE	uniQure NV
2025/01/09	06:21	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:QURE	uniQure NV
2025/01/08	21:05	GlobeNewswire Inc.	uniQure Announces Pricing of its Public Offering	NASDAQ:QURE	uniQure NV
2025/01/08	07:25	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:QURE	uniQure NV
2025/01/08	06:49	GlobeNewswire Inc.	uniQure Announces Proposed Public Offering	NASDAQ:QURE	uniQure NV
2025/01/08	06:42	Edgar (US Regulatory)	Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers	NASDAQ:QURE	uniQure NV
2024/12/11	06:54	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:QURE	uniQure NV
2024/12/11	06:33	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:QURE	uniQure NV
2024/12/10	21:22	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:QURE	uniQure NV
2024/12/10	21:05	GlobeNewswire Inc.	uniQure Announces Alignment with FDA on Key Elements of Accelerated Approval Pathway for AMT-130 in Huntington’s Disease	NASDAQ:QURE	uniQure NV
2024/11/21	23:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:QURE	uniQure NV
2024/11/21	21:05	GlobeNewswire Inc.	uniQure Announces Dosing of First Patient in GenTLE Phase I/IIa Clinical Trial of AMT-260 for the Treatment of Refractory Mesial Temporal Lobe Epilepsy	NASDAQ:QURE	uniQure NV
2024/11/15	02:01	Edgar (US Regulatory)	Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]	NASDAQ:QURE	uniQure NV
2024/11/05	23:08	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:QURE	uniQure NV
2024/11/05	22:02	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:QURE	uniQure NV
2024/11/05	21:05	GlobeNewswire Inc.	uniQure Announces Third Quarter 2024 Financial Results and Highlights Recent Company Progress	NASDAQ:QURE	uniQure NV
2024/10/26	10:48	Edgar (US Regulatory)	Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]	NASDAQ:QURE	uniQure NV
2024/10/26	10:48	Edgar (US Regulatory)	Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]	NASDAQ:QURE	uniQure NV
2024/10/15	20:49	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:QURE	uniQure NV
2024/10/15	20:05	GlobeNewswire Inc.	uniQure Announces Dosing of First Patient in Phase I/II Clinical Trial of AMT-162 for the Treatment SOD1-ALS	NASDAQ:QURE	uniQure NV
2024/09/23	20:35	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:QURE	uniQure NV
2024/09/23	20:05	GlobeNewswire Inc.	uniQure Announces Orphan Drug Designation Granted to AMT-191 for the Treatment of Fabry Disease	NASDAQ:QURE	uniQure NV
2024/08/15	20:48	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:QURE	uniQure NV
2024/08/15	20:05	GlobeNewswire Inc.	uniQure Announces Dosing of First Patient in Phase I/IIa Clinical Trial of AMT-191 for the Treatment of Fabry Disease	NASDAQ:QURE	uniQure NV
2024/08/01	21:54	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:QURE	uniQure NV
2024/08/01	20:51	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:QURE	uniQure NV
2024/08/01	20:43	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:QURE	uniQure NV
2024/08/01	20:05	GlobeNewswire Inc.	uniQure Announces Second Quarter 2024 Financial Results and Provides Company Update	NASDAQ:QURE	uniQure NV
2024/07/23	20:10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:QURE	uniQure NV
2024/07/23	20:05	GlobeNewswire Inc.	uniQure Announces Closing of Sale of Manufacturing Facility to Genezen	NASDAQ:QURE	uniQure NV